IQBAL J. HUSSAIN

Insider Reports History

Location
Cambridge, United Kingdom
Signature
/s/ Raphael Deferiere, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by IQBAL J. HUSSAIN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Centessa Pharmaceuticals plc Chief Legal Officer Ordinary Shares 117,645 $2,942,301 $25.01 02 Feb 2026 Direct
Centessa Pharmaceuticals plc Chief Legal Officer Ordinary Shares 5,500 $137,555 $25.01 30 Jan 2026 By spouse
Centessa Pharmaceuticals plc Chief Legal Officer Share Option (right to buy) 160,000 02 Feb 2026 Direct

Insider Reports Filed by IQBAL J. HUSSAIN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CNTA Centessa Pharmaceuticals plc 30 Jan 2026 6 -$1,196,072 4 Chief Legal Officer 03 Feb 2026, 18:59
CNTA Centessa Pharmaceuticals plc 17 Nov 2025 3 -$130,795 4 General Counsel 18 Nov 2025, 16:18
CNTA Centessa Pharmaceuticals plc 15 Oct 2025 3 -$99,399 4 General Counsel 16 Oct 2025, 16:13
CNTA Centessa Pharmaceuticals plc 15 Sep 2025 3 -$96,061 4 General Counsel 15 Sep 2025, 18:37
CNTA Centessa Pharmaceuticals plc 09 Sep 2025 6 -$606,502 4 General Counsel 11 Sep 2025, 17:47
CNTA Centessa Pharmaceuticals plc 15 Aug 2025 3 -$68,340 4 General Counsel 15 Aug 2025, 18:13
CNTA Centessa Pharmaceuticals plc 15 Jul 2025 3 -$54,527 4 General Counsel 17 Jul 2025, 16:15
CNTA Centessa Pharmaceuticals plc 24 Jun 2025 3 -$98,138 4 General Counsel 25 Jun 2025, 19:43
CNTA Centessa Pharmaceuticals plc 01 May 2025 3 -$2,538 4 General Counsel 02 May 2025, 16:17
CNTA Centessa Pharmaceuticals plc 25 Apr 2025 6 -$46,434 4 General Counsel 29 Apr 2025, 16:58
CNTA Centessa Pharmaceuticals plc 17 Mar 2025 3 -$63,657 4 General Counsel 19 Mar 2025, 16:47
CNTA Centessa Pharmaceuticals plc 18 Feb 2025 4 -$62,025 4 General Counsel 19 Feb 2025, 17:59
CNTA Centessa Pharmaceuticals plc 01 Feb 2025 2 -$217,913 4 General Counsel 04 Feb 2025, 16:56
CNTA Centessa Pharmaceuticals plc 15 Jan 2025 3 -$56,700 4 General Counsel 17 Jan 2025, 16:15
CNTA Centessa Pharmaceuticals plc 31 Dec 2024 1 -$122,952 4 General Counsel 31 Dec 2024, 16:32
CNTA Centessa Pharmaceuticals plc 16 Dec 2024 3 -$1,238,716 4 General Counsel 17 Dec 2024, 17:10
CNTA Centessa Pharmaceuticals plc 30 Sep 2024 1 -$118,741 4 General Counsel 02 Oct 2024, 16:32
CNTA Centessa Pharmaceuticals plc 30 Jun 2024 1 -$67,906 4 General Counsel 02 Jul 2024, 16:34
CNTA Centessa Pharmaceuticals plc 31 Mar 2024 1 -$84,976 4 General Counsel 02 Apr 2024, 16:16
CNTA Centessa Pharmaceuticals plc 01 Feb 2024 3 -$64,578 4 General Counsel 02 Feb 2024, 17:09
CNTA Centessa Pharmaceuticals plc 31 Dec 2023 1 -$59,859 4 General Counsel 02 Jan 2024, 19:44
CNTA Centessa Pharmaceuticals plc 30 Sep 2023 1 -$48,654 4 General Counsel 03 Oct 2023, 17:00
CNTA Centessa Pharmaceuticals plc 30 Jun 2023 1 -$41,914 4 General Counsel 03 Jul 2023, 17:34
CNTA Centessa Pharmaceuticals plc 31 Mar 2023 1 -$27,612 4 General Counsel 04 Apr 2023, 17:03
CNTA Centessa Pharmaceuticals plc 01 Feb 2023 2 $0 4 General Counsel 03 Feb 2023, 16:13
CNTA Centessa Pharmaceuticals plc 31 Dec 2022 1 -$12,388 4 General Counsel 04 Jan 2023, 18:23
CNTA Centessa Pharmaceuticals plc 30 Sep 2022 1 -$48,641 4 General Counsel 13 Jan 2023, 16:42
CNTA Centessa Pharmaceuticals plc 30 Sep 2022 0 $0 4/A General Counsel 23 Nov 2022, 16:00
CNTA Centessa Pharmaceuticals plc 01 Jul 2022 1 $0 4 General Counsel 06 Jul 2022, 18:15
CNTA Centessa Pharmaceuticals plc 01 Feb 2022 1 $0 4 General Counsel 03 Feb 2022, 17:30
CNTA Centessa Pharmaceuticals plc 02 Jun 2021 2 +$170,000 4 General Counsel 04 Jun 2021, 17:00
CNTA Centessa Pharmaceuticals plc 27 May 2021 3 $0 4 General Counsel 01 Jun 2021, 20:59
CNTA Centessa Pharmaceuticals plc 27 May 2021 0 $0 3 General Counsel 27 May 2021, 20:25